Stock LADX LADRX CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. LadRx Corporation

Equities

LADX

US2328287071

Market Closed - OTC Markets
Other stock markets
 09:30:02 2024-05-16 am EDT 		5-day change 1st Jan Change
3.2 USD +3.23% Intraday chart for LadRx Corporation +6.67% +146.15%
Mar. 27 LadRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jan. 11 Xoma to Make $1 Million Milestone Payment to LadRx After FDA Accepts Zevra Application for Arimoclomol DJ

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LADX Stock
  4. News LadRx Corporation
  5. Analyst Reco.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW